Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.10
Delayed Data
As of Jul 31
 -0.10 / -0.98%
Today’s Change
5.69
Today|||52-Week Range
13.84
-10.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues27.8M28.0M33.9M14.8M
 
 
 
 
 
Depreciation And Amortization1.4M570.0K412.0K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income------13.8M
 
 
General Expenses40.4M51.2M38.6M43.8M
 
 
 
 
 
Research And Development33.8M43.6M30.7M35.7M
 
 
 
 
 
Total Operating Expenses41.7M51.7M39.0M44.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.9M-23.7M-5.1M-30.0M
 
 
 
 
 
Interest Expense On Debt4.6M4.6M4.6M4.6M
 
 
 
 
 
Other Expenses161.0K265.0K151.0K113.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.3M-28.0M-9.5M-34.4M
 
 
 
 
 
Minority Interest-181.0K-137.0K-219.0K-327.0K
 
 
 
 
 
Net Income-18.1M-27.9M-9.7M-34.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS103.8M104.9M106.7M107.1M
 
 
 
 
 
Shares To Calculate EPS Diluted103.8M104.9M106.7M107.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.27-$0.09-$0.32
 
 
 
 
 
EPS Diluted-$0.17-$0.27-$0.09-$0.32